Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls.
This three-day course provides insights into all parts that should be addressed to effectively develop new biologics, from discovery to product launch. The course is given in English.
The course is organized in cooperation between Läkemedelsakademin and SwedenBIO.
SwedenBIO members get a 3000SEK discount on the regular feel.
